Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V C Jordan

Showing results (101-110 of 365) with videos related to

Pageof 37
Sort By:
Hematology/Oncology Clinics of North America|June 11, 1999
Hormonal therapy for breast cancer. An updateW J Gradishar, V C Jordan
The Journal of Steroid Biochemistry and Molecular Biology|November 1, 1995
Nomegestrol acetate, a clinically useful 19-norprogesterone derivative which lacks estrogenic activityW H Catherino, V C Jordan
Breast Cancer Research and Treatment|January 1, 1993
William L. McGuire Memorial Symposium. Drug resistance to tamoxifen during breast cancer therapyD M Wolf, V C Jordan
Anti-Cancer Drugs|August 1, 1995
Possible mechanisms in the emergence of tamoxifen-resistant breast cancerD A Tonetti, V C Jordan
Progress in Clinical and Biological Research|January 1, 1997
Targeted antiestrogensD A Tonetti, V C Jordan
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1993
A laboratory model to explain the survival advantage observed in patients taking adjuvant tamoxifen therapyD M Wolf, V C Jordan
British Medical Bulletin|March 20, 2001
Novel agents to modulate oestrogen actionR C Dardes, V C Jordan
Journal of the National Cancer Institute|April 15, 1992
Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptorS Y Jiang, V C Jordan
Cancer Letters|March 23, 1995
The biological action of cDNAs from mutated estrogen receptors transfected into breast cancer cellsW H Catherino, V C Jordan
Molecular Aspects of Medicine|June 1, 1997
Molecular mechanisms and future uses of antiestrogensV C Jordan, W J Gradishar
Pageof 37

Showing results (101-110 of 365) with videos related to

Sort By:
Pageof 37
Hematology/Oncology Clinics of North America|June 11, 1999
Hormonal therapy for breast cancer. An updateW J Gradishar, V C Jordan
The Journal of Steroid Biochemistry and Molecular Biology|November 1, 1995
Nomegestrol acetate, a clinically useful 19-norprogesterone derivative which lacks estrogenic activityW H Catherino, V C Jordan
Breast Cancer Research and Treatment|January 1, 1993
William L. McGuire Memorial Symposium. Drug resistance to tamoxifen during breast cancer therapyD M Wolf, V C Jordan
Anti-Cancer Drugs|August 1, 1995
Possible mechanisms in the emergence of tamoxifen-resistant breast cancerD A Tonetti, V C Jordan
Progress in Clinical and Biological Research|January 1, 1997
Targeted antiestrogensD A Tonetti, V C Jordan
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1993
A laboratory model to explain the survival advantage observed in patients taking adjuvant tamoxifen therapyD M Wolf, V C Jordan
British Medical Bulletin|March 20, 2001
Novel agents to modulate oestrogen actionR C Dardes, V C Jordan
Journal of the National Cancer Institute|April 15, 1992
Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptorS Y Jiang, V C Jordan
Cancer Letters|March 23, 1995
The biological action of cDNAs from mutated estrogen receptors transfected into breast cancer cellsW H Catherino, V C Jordan
Molecular Aspects of Medicine|June 1, 1997
Molecular mechanisms and future uses of antiestrogensV C Jordan, W J Gradishar
Pageof 37